Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
AngioDynamics appointed Eric Honroth as President and Chief Executive Officer, effective November 2, 2026, succeeding the retiring James C. Clemmer. Honroth's employment agreement includes an annual base salary of $735,000, a target annual bonus of 95% of base salary, and eligibility for long-term incentive awards under the company's equity plan.
Crescent Energy Signs $4.22B M&A Deal with Devon Energy Production Company, L.P.
Crescent Energy has entered into a definitive agreement to acquire Eagle Ford assets from Devon Energy for $4.22 billion in cash. The acquisition adds approximately 68 Mboe/d of net production and over 600 Tier 1 drilling locations adjacent to Crescent's existing operations. The deal is expected to close in late 2026 or early 2027 and includes $140 million in identified annual synergies.
Value
$4.22B
Counterparty
Devon Energy Production Company, L.P.
Earnings call
Oct 8, 2026, 8:00 AM ET
“This acquisition represents a significant step forward for Crescent, adding high-quality assets at an attractive valuation in the heart of one of our core operating areas. We know these assets exceptionally well through our longstanding minerals ownership and nearby operations, and see meaningful opportunity to make them even better. The transaction solidifies Crescent’s world-class Eagle Ford position and creates significant additional value creation opportunities through our proven operating strategy.”
David Rockecharlie, Chief Executive Officer of Crescent Energy
Shoulder Innovations announced the limited user release and commercial launch of InSet Go, its next-generation glenoid implant for anatomic shoulder arthroplasty. The launch follows the successful completion of the first surgical case and aims to improve procedural efficiency while maintaining the company's clinically-proven design for implant stability.
Editas Medicine received approval to initiate its Phase 1/2 Strive clinical trial for EDIT-401 in Australia, targeting patients with heterozygous familial hypercholesterolemia. The company expects to begin patient dosing in 2026 and report initial safety and tolerability data in the first quarter of 2027. Additionally, the company will present new preclinical data demonstrating durable LDL-C reduction at the AHA Scientific Sessions in November 2026.
Tetra Technologies Debt Financing Update with Silver Point Finance, LLC
TETRA Technologies entered into a first amendment to its term loan credit agreement with Silver Point Finance to improve borrowing terms. The amendment reduces the interest rate from SOFR + 5.75% to SOFR + 5.00%, extends the maturity date to December 31, 2030, and defers quarterly amortization payments until June 2028.
Tilray Brands reported record Q1 fiscal 2027 net revenue of $257.1 million, a 23% increase year-over-year, driven by double-digit growth in international cannabis, beverage, and pharmaceutical distribution. The company expanded its gross margin to 30% and reduced its outstanding debt by $42 million fiscal year-to-date, ending the quarter in a net cash position.
Term
Q1 2027
“Tilray’s record first-quarter revenue and gross profit demonstrate the power of the diversified platform we have built and the momentum we are creating across cannabis, beverage, hospitality, wellness and pharmaceutical distribution. We are no longer dependent on a single market or regulatory catalyst. We have multiple engines of growth, a scaled international footprint and the ability to convert scale into stronger margins, greater efficiency and sustainable, profitable growth.”
Irwin D. Simon, Chairman and Chief Executive Officer, Tilray Brands
“Our global platform is translating into leadership positions across our core categories. In cannabis, Tilray is a leading cannabis producer, with more than 6 million square feet of cultivation capacity across Canada, Portugal and Germany, and a leading low-cost production base in the world’s largest legally regulated markets, supported by one of the largest EU-GMP certified footprints in the world.”
Irwin D. Simon, Chairman and Chief Executive Officer, Tilray Brands
Henry Schein appointed Emmanuel Caprais as Senior Vice President and CFO, effective November 4, 2026, succeeding Ronald N. South who will transition to a Senior Advisor role. Caprais will receive an annual base salary of $750,000, a target bonus of $750,000, and a 2027 long-term incentive award estimated at $2.5 million.
Kathryn Rowen, Executive Vice President and Chief Transformation and Operations Officer, notified Vontier Corporation of her decision to resign effective October 16, 2026. Her departure is to pursue another opportunity, and no successor was named in the filing.
Atrium Therapeutics entered into a securities purchase agreement for a $50 million private placement (PIPE) involving the sale of 5,170,384 common shares and pre-funded warrants for 1,134,930 shares. The offering was priced at $7.93 per share and included participation from several institutional investors. Proceeds will be used to fund the development of lead product candidates and extend the company's cash runway through 2028.
Value
$50M
Counterparty
Sirenia Capital Management LP, Aberdeen Investments, Montanova, Sessa Capital, Casdin Capital
The ICC International Court of Arbitration issued a partial final award finding that Venture Global breached its obligation to timely declare the commercial operation date (COD) of the Calcasieu Project under its SPA with Galp Trading S.A. While a separate damages hearing is expected in 2027 or 2028, any final award will be subject to a $170 million seller aggregate liability cap. Venture Global expressed disappointment, noting the ruling contradicts prior arbitration findings involving Shell and Repsol.
Helen of Troy reported second quarter fiscal 2027 results with consolidated net sales growth of 2.1% to $440.9 million and GAAP net income of $4.6 million. The company raised its full-year fiscal 2027 outlook for GAAP diluted EPS, Adjusted EBITDA, and free cash flow while narrowing its net sales guidance range.
Term
Q2 2027
Earnings call
Oct 8, 2026, 9:00 AM ET
“Our second quarter results reflect continued progress against our multi-year roadmap. Sales were in line, and Adjusted EBITDA and Adjusted EPS were better than expected, without including the net tariff refund benefit in the quarter. Sales growth was broad-based across Home & Outdoor, Wellness, and International, with improving fundamentals across the balance of the portfolio. We also continued to strengthen our balance sheet, generate free cash flow, and focus resources on the opportunities with the greatest potential to create value.”
G. Scott Uzzell, Chief Executive Officer
“While there is still meaningful work ahead, we are encouraged by the progress we are making to build a Better Helen of Troy on the road to becoming a Bigger Helen of Troy. We plan to continue making targeted investments in our brands, capabilities, and organization, including reinvesting the vast majority of tariff refunds, while allowing a portion to support near-term earnings and liquidity.”
Nova Minerals Capacity Expansion: $43.4M Investment
Nova Minerals has received all key plant equipment at Port MacKenzie, Alaska, to begin construction of its antimony processing and refinery facility. The project aims to establish a vertically integrated U.S. domestic antimony supply chain and is supported by a $43.4 million award from the U.S. Department of War.
51Talk Online Education Group CEO Jack Jiajia Huang Buys $32.3M of Stock
Jack Jiajia Huang, CEO, bought 2,812,140 shares of 51Talk Online Education Group at $11.48 to $11.50 a share (average $11.50) in 6 transactions, worth $32.3M in total between Sep 17, 2026 and Sep 25, 2026. Shares held after the trade: 38,427,300 (+3.3%).
Frequency Electronics held its Annual Meeting of Stockholders on October 7, 2026, where shareholders elected five directors to one-year terms. Stockholders also ratified Grant Thornton LLP as the independent auditor for fiscal year 2027 and approved executive compensation on a non-binding advisory basis.
Perspective Therapeutics announced that the FDA has granted Fast Track Designation for PSV359, an investigational FAP-targeted alpha-particle therapy. The designation is for the treatment of adult patients with locally advanced unresectable and/or metastatic fibroblast activation protein-positive solitary fibrous tumors (SFTs).
Drilling Tools International Signs $81M M&A Deal with Saltire Energy Limited & Foxley Energy Limited
Drilling Tools International (DTI) entered into a definitive agreement to acquire Saltire Energy Limited and Foxley Energy Limited for approximately $81 million in cash and 17.4 million shares of common stock. The acquisition significantly expands DTI's international presence, increasing its Eastern Hemisphere revenue contribution from 18% to approximately 40%. The transaction is expected to close in the first quarter of 2027 and be immediately accretive to key financial metrics.
Haemonetics provided a status update on its non-exclusive supply agreement with CSL Plasma, noting that CSL expects to complete the rollout of NexSys PCS devices and Persona PLUS disposables across all its U.S. collection centers by the end of 2027. The company maintained its existing fiscal 2027 guidance and plans to provide a detailed financial impact update during its November 2026 earnings call.
Prudential Financial's Japanese subsidiary, Prudential Life Insurance Co., Ltd., published the findings of a Special Investigation Committee (SIC) report regarding previously disclosed misconduct by sales employees. The report identified structural problems in the company's management framework, business model, and organizational culture that allowed inappropriate monetary conduct to persist. The company is implementing structural reforms, including changes to compensation systems and sales management, to prevent recurrence and ensure customer-centric operations.
New ERA Energy & Digital $116M Debt Financing with Macquarie Bank Limited
New Era Energy & Digital's subsidiaries entered into a $116.0 million Letter of Credit Reimbursement Agreement with Macquarie Bank Limited to provide credit support for a Power Purchase Agreement with Luminant. The facility is secured by $118.3 million in cash collateral, partially funded by a $60.0 million drawdown from an existing term loan which also triggered the issuance of 413,055 warrants to the lender.
The Brink's Company announced that the UK Competition and Markets Authority (CMA) has accepted in principle its proposed remedy to divest NoteMachine/TestLink UK to address antitrust concerns. This regulatory progress allows the pending acquisition of NCR Atleos to remain on track for an expected close in early Q1 2027. Brink's reaffirmed its expectation of $200 million in annual run-rate cost synergies despite the required divestiture.
Valion Bio, Inc. entered into a letter agreement with 3i, LP to issue 50 shares of Series B Non-Voting Convertible Preferred Stock and warrants for 1,539 shares of common stock. The transaction resulted in gross proceeds of $50,000 as part of an ongoing securities purchase agreement. The warrants have an initial exercise price of $2.5520 per share.
Distribution Solutions Group Signs $800M M&A Deal with LKCM Headwater Investments, LLC
Distribution Solutions Group (DSG) announced the pricing of an upsized $800 million senior notes offering to fund its previously announced take-private merger with affiliate LKCM Headwater. Under the deal, LKCM Headwater will acquire all remaining shares of DSG common stock for $35.00 per share in cash, with the notes proceeds also being used to repay existing debt.
Eva Live $1.88M Debt Financing with Dune Equity Holdings LLC
Eva Live Inc. entered into a securities purchase agreement with Dune Equity Holdings LLC for the issuance of a 12% secured promissory note in the principal amount of up to $1.875 million. The first tranche of $937,500 was funded on October 2, 2026, with proceeds intended for business development and general working capital.
Quetta Acquisition Corporation announced it will convene and immediately adjourn its special meeting of stockholders from October 8, 2026, to October 9, 2026. The adjournment is intended to provide additional time for the company to solicit proxies for the proposals described in its definitive proxy statement.
Oil-Dri Corp of America $100M Debt Financing with BMO Bank N.A.
Oil-Dri Corporation of America amended its credit agreement with BMO Bank to increase its revolving line of credit from $75 million to $100 million and extended the maturity date to October 7, 2031. Additionally, the company amended its note purchase agreement with PGIM (Prudential) to increase the available shelf note capacity to $150 million and extended the issuance period through October 2029.
Texas Ventures Acquisition III Debt Financing Update with Yorkville Acquisition Sponsor II, LLC
Texas Ventures Acquisition III Corp issued a $250,000 convertible unsecured promissory note to its sponsor, Yorkville Acquisition Sponsor II, LLC, for working capital purposes. The note is non-interest bearing and is payable upon the consummation of the company's initial business combination or its winding up. At the sponsor's election, the principal can be converted into units at a price of $10.00 per unit upon the completion of a business combination.
NextNRG, Inc. completed its reincorporation from Delaware to Nevada effective October 7, 2026, following shareholder approval at its 2025 annual meeting. In connection with the move, the company adopted new articles of incorporation and bylaws and entered into an amended voting and standstill agreement with certain stockholders that extends through December 31, 2028.
XWELL Signs $2.7M M&A Deal with Express Wellness Group, LLC
XWELL's subsidiary XpresTest repurchased all outstanding restricted stock awards for $2.7 million to simplify its capitalization ahead of a previously announced divestiture. This action ensures XWELL now owns 100% of XpresTest before the final sale of the entity to Express Wellness Group, LLC. The repurchase price of $9,634.09 per share matches the valuation agreed upon in the original securities purchase agreement.
News Corp provided a daily update on its $1 billion stock repurchase program, which authorizes the buyback of Class A and Class B common stock. The filing includes daily transaction notifications required by the Australian Securities Exchange (ASX). The program was originally authorized on July 15, 2025.
General Dynamics announced that Danny Deep, the company's current President, has been elected as Chief Executive Officer, effective January 1, 2027. He will succeed Phebe N. Novakovic, who has served as CEO since 2013 and will transition to the role of Executive Chairman of the board of directors.